Article Details
Retrieved on: 2021-01-26 11:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The Company's validated, proprietary F.I.R.S.T™ technology platform simultaneously identifies both targets and the antibodies that bind to them, ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here